Neuromuscular

Episodes 17-25 of 25

• 

  RestartResume

  Autoantibodies in CIDP: Prevalence and Diagnostic Implications

  RestartResume

  Autoantibodies in CIDP: Prevalence and Diagnostic Implications

  MinuteCE®

  Autoantibodies in CIDP: Prevalence and Diagnostic Implications

  Jeffrey Allen, MD; Nicholas J. Silvestri, MD

  1.00 program credit

  Jeffrey Allen, MD; Nicholas J. Silvestri, MD

  1.00 program credit

• 

  RestartResume

  Navigating CIDP Treatments: IVIg and Steroid Advantages and Limitations

  RestartResume

  Navigating CIDP Treatments: IVIg and Steroid Advantages and Limitations

  MinuteCE®

  Navigating CIDP Treatments: IVIg and Steroid Advantages and Limitations

  Jeffrey Allen, MD; Nicholas J. Silvestri, MD

  1.00 program credit

  Jeffrey Allen, MD; Nicholas J. Silvestri, MD

  1.00 program credit

• 

  RestartResume

  CIDP Monitoring Challenges: Suboptimal Responses in CIDP Treatment

  RestartResume

  CIDP Monitoring Challenges: Suboptimal Responses in CIDP Treatment

  MinuteCE®

  CIDP Monitoring Challenges: Suboptimal Responses in CIDP Treatment

  Jeffrey Allen, MD; Nicholas J. Silvestri, MD

  1.00 program credit

  Jeffrey Allen, MD; Nicholas J. Silvestri, MD

  1.00 program credit

• 

  RestartResume

  Implementing CIDP Clinical Guidelines: Optimizing Therapy

  RestartResume

  Implementing CIDP Clinical Guidelines: Optimizing Therapy

  MinuteCE®

  Implementing CIDP Clinical Guidelines: Optimizing Therapy

  Nicholas J. Silvestri, MD; Jeffrey Allen, MD

  1.00 program credit

  Nicholas J. Silvestri, MD; Jeffrey Allen, MD

  1.00 program credit

• 

  RestartResume

  Clinical Benefits of FcRn Inhibitors: Innovations in CIDP Management and Treatment

  RestartResume

  Clinical Benefits of FcRn Inhibitors: Innovations in CIDP Management and Treatment

  MinuteCE®

  Clinical Benefits of FcRn Inhibitors: Innovations in CIDP Management and Treatment

  Nicholas J. Silvestri, MD; Jeffrey Allen, MD

  1.00 program credit

  Nicholas J. Silvestri, MD; Jeffrey Allen, MD

  1.00 program credit

• 

  RestartResume

  Comprehensive CIDP Care: The Role of Multidisciplinary Teams and Patient-Reported Outcomes

  RestartResume

  Comprehensive CIDP Care: The Role of Multidisciplinary Teams and Patient-Reported Outcomes

  MinuteCE®

  Comprehensive CIDP Care: The Role of Multidisciplinary Teams and Patient-Reported Outcomes

  Jeffrey Allen, MD; Nicholas J. Silvestri, MD

  1.00 program credit

  Jeffrey Allen, MD; Nicholas J. Silvestri, MD

  1.00 program credit

• 

  RestartResume

  Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)

  RestartResume

  Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)

  CME/CE

  Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)

  John Russell, MD; Noel Dasgupta, MD, FACC

  0.50 credits

  John Russell, MD; Noel Dasgupta, MD, FACC

  0.50 credits

• 

  RestartResume

  Case Concepts in Generalized Myasthenia Gravis: Balancing the Need for Glucocorticoids and Integrating FcRn Inhibitors Into Treatment Plans

  RestartResume

  Case Concepts in Generalized Myasthenia Gravis: Balancing the Need for Glucocorticoids and Integrating FcRn Inhibitors Into Treatment Plans

  CME/CE

  Case Concepts in Generalized Myasthenia Gravis: Balancing the Need for Glucocorticoids and Integrating FcRn Inhibitors Into Treatment Plans

  Michael Erdman, PharmD, BCCCP; Ali A. Habib, MD

  1.00 credit

  Michael Erdman, PharmD, BCCCP; Ali A. Habib, MD

  1.00 credit

• 

  RestartResume

  Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies

  RestartResume

  Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies

  CME/CE

  Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies

  Perry B. Shieh, MD, PhD

  1.00 credit

  Perry B. Shieh, MD, PhD

  1.00 credit